Epigenetics and human disease

Annual Review of Genomics and Human Genetics

Volumn 5, Issue , 2004, Pages 479-510

  Jiang, Yong Hui ^a   Bressler, Jan ^a   Beaudet, Arthur L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chromatin remodeling; Complex traits; DNA methylation; Genomic imprinting

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; CHROMATIN STRUCTURE; DIZYGOTIC TWINS; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE DUPLICATION; GENE EXPRESSION; GENE MUTATION; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC TRAIT; GENOME IMPRINTING; HAPPY PUPPET SYNDROME; HERITABILITY; HUMAN; MALE; MONOGENIC DISORDER; MONOZYGOTIC TWINS; PHENOTYPE; PRADER WILLI SYNDROME; PSEUDOHYPOPARATHYROIDISM; REVIEW; SILVER RUSSELL SYNDROME; UNIPARENTAL DISOMY;

ALLELES; CHROMATIN; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; GENETIC DISEASES, INBORN; GENOMIC IMPRINTING; HUMANS; MALE; MODELS, GENETIC; PEDIGREE;

EID: 3442890774     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.5.061903.180014     Document Type: Review

References (174)

1. Albrecht U, Sutcliffe JS, Cattanach BM, Beechey CV, Armstrong D, et al. 1997. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 17:75-78
2. Allshire R. 2002. Molecular biology. RNAi and heterochromatin - a hushed-up affair. Science 297:1818-19
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23:185-88
4. Ausio J, Levin DB, De Amorim GV, Bakker S, MacLeod PM. 2003. Syndromes of disordered chromatin remodeling. Clin. Genet. 64:83-95
5. Bandyopadhyay D, Medrano EE. 2003. The emerging role of epigenetics in cellular and organismal aging. Exp. Gerontol. 38:1299-307
6. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM. 1993. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev. 7:1663-73
7. Beaudet AL. 2002. Is medical genetics neglecting epigenetics? Genet. Med. 4:399-402
8. Beaudet AL, Jiang J. 2002. A rheostat model for a rapid and reversible form of imprinting-dependent evolution. Am. J. Hum. Genet. 70:1389-97
9. Backer PB, Horz W. 2002. ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 71:247-73
10. Bell AC, West AG, Felsenfeld G. 1999. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98:387-96
11. Bestor TH, Tycko B. 1996. Creation of genomic methylation patterns. Nat. Genet. 12:363-67
12. Bickmore WA, van der Maarel SM. 2003. Perturbations of chromatin structure in human genetic disease: recent advances. Hum. Mol. Genet. 12:R207-13
13. Bird A. 2001. Molecular biology. Methylation talk between histones and DNA. Science 294:2113-15
14. Boumil RM, Lee JT. 2001. Forty years of decoding the silence in X-chromosome inactivation. Hum. Mol. Genet. 10:2225-32
15. Bourc'his D, Xu GL, Lin CS, Bollman B, Bester TH. 2001. Dnmt3L and the establishment of maternal genomic imprints. Science 294:2536-39
16. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. 2003. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum. Genet. 113:149-53
17. Brehm A, Tufteland KR, Aasland R, Backer PB. 2004. The many colours of chromodomains. Bioessays 26:133-40
18. Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, El Maarri O, Horsthemke B. 2003. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am. J. Hum. Genet. 72:571-77
19. Cassidy S, Dykens E, Williams C. 2000. Prader-Willi and Angelman syndromes: sister imprinted disorders. Am. J. Med. Genet. 97:136-46
20. Cattanach BM, Beechey CV. 1990. Autosomal and X-chromosome imprinting. Development (Suppl.) 63-72
21. Cattanach BM, Kirk M. 1985. Differential activity of maternally and paternally derived chromosome regions in mice. Nature 315:496-98
22. Chao W, Huynh KD, Spencer RJ, Davidow LS, Lee JT. 2002. CTCF, a candidate trans-acting factor for X-inactivation choice. Science 295:345-47
23. Chen CZ, Li L, Lodish HF, Bartel DR 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86
24. Chen WG, Chang Q, Lin Y, Meissner A, West AE, et al. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885-89
25. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, et al. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10:433-43
26. Chess A. 1998. Expansion of the allelic exclusion principle? Science 279:2067-68
27. Clayton-Smith J. 2003. Genomic imprinting as a cause of disease. Br. Med. J. 327:1121-22
28. Coffee B, Zhang F, Ceman S, Warren ST, Reines D. 2002. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am. J. Hum. Genet. 71:923-32
29. Coffee B, Zhang F, Warren ST, Reines D. 1999. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22:98-101
30. Constancia M, Pickard B, Kelsey G, Reik W. 1998. Imprinting mechanisms. Genome Res. 8:881-900
31. Cox GF, Burger J, Lip V, Mau UA, Sperling K, et al. 2002. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am. J. Hum. Genet. 71:162-64
32. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, et al. 2003. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299:1753-55
33. D'Esposito M, Ciccodicola A, Gianfrancesco F, Esposito T, Flagiello L, et al. 1996. A synaptobrevin-like gene in the Xq28 pseudoautosomal region undergoes X inactivation. Nat. Genet. 13:227-29
34. DeBaun MR, Niemitz EL, Feinberg AR 2003. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am. J. Hum. Genet. 72:156-60
35. DeChiara TM, Robertson EJ, Efstratiadis A. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-59
36. Dennis C. 2003. Epigenetics and disease: altered states. Nature 421:686-88
37. Eddy SR. 2001. Non-coding RNA genes and the modern RNA world. Nat. Rev. Genet. 2:919-29
38. Engel E, Antonarakis SE. 2002. Genomic Imprinting and Uniparental Disomy in Medicine: Clinical and Molecular Aspects. New York: Wiley-Liss
39. Ensminger AW, Chess A. 2004. Coordinated replication timing of monoallelically expressed genes along human autosomes. Hum. Mol. Genet. 13:651-58
40. Feil R, Walter J, Allen ND, Reik W. 1994. Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development 120:2933-43
41. Felsenfeld G, Groudine M. 2003. Controlling the double helix. Nature 421:448-53
42. Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA. 1993. Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 362:751-55
43. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, et al. 2000. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101-6
44. Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, et al. 2003. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23:9418-27
45. Fournier C, Goto Y, Ballestar E, Delaval K, Hever AM, et al. 2002. Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J. 21:6560-70
46. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, et al. 2002. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA 99:5606-11
47. Gibbons RJ, McDowell TL, Raman S, O'Rourke DM, Garrick D, et al. 2000. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet. 24:368-71
48. Gibbons RJ, Pellagatti A, Garrick D, Wood WG, Malik N, et al. 2003. Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nat. Genet. 34:446-49
49. Grosveld F. 1999. Activation by locus control regions? Curr. Opin. Genet. Dev. 9:152-57
50. Gruenbaum Y, Cedar H, Razin A. 1982. Substrate and sequence specificity of a eukaryotic DNA methylase. Nature 295:620-22
51. Hajkova P, Erhardt S, Lane N, Haaf T, El Maarri O, et al. 2002. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 117:15-23
52. Hall JG. 1990. How imprinting is relevant to human disease. Development (Suppl.) 141-48
53. Hall JG. 1997. Genomic imprinting: nature and clinical relevance. Annu. Rev. Med. 48:35-44
54. Hammer S, Dorrani N, Dragich J, Kudo S, Schanen C. 2002. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8:94-98
55. Hampsey M, Reinberg D. 2003. Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation. Cell 113:429-32
56. Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, et al. 1999. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 96:14412-17
57. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. 2000. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486-89
58. Hata K, Okano M, Lei H, Li E. 2002. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 129:1983-93
59. Hekimi S, Guarente L. 2003. Genetics and the specificity of the aging process. Science 299:1351-54
60. Hendrich B, Bickmore W. 2001. Human diseases with underlying defects in chromatin structure and modification. Hum. Mol. Genet. 10:2233-42
61. Hendrich B, Bird A. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 18:6538-47
62. Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A. 2001. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15:710-23
63. Herbert A. 2004. The four Rs of RNA-directed evolution. Nat. Genet. 36:19-25
64. Hermann A, Schmitt S, Jeltsch A. 2003. The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity. J. Biol. Chem. 278:31717-21
65. Hodges MD, Rees HC, Seckl MJ, Newlands ES, Fisher RA. 2003. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J. Med. Genet. 40:e95
66. Holliday R. 1994. Epigenetics: an overview. Dev. Genet. 15:453-57
67. Holliday R. 2002. Epigenetic mechanisms of gene regulation, ed. V Russo, RA Martienssen, AD Riggs, pp. 5-27. Cold Spring Harbor, NY: Cold Spring Harbor Press
68. Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, et al. 2001. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 104:829-38
69. Huang C, Sloan EA, Boerkoel CF. 2003. Chromatin remodeling and human disease. Curr. Opin. Genet. Dev. 13:246-52
70. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, et al. 2003. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361:1693-99
71. Ishizuka A, Siomi MC, Siomi H. 2002. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 16:2497-508
72. Issa JP, Baylin SB. 1996. Epigenetics and human disease. Nat. Med. 2:281-82
73. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl.):245-54
74. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-80
75. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, et al. 2004. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 7:113-17
76. Jirtle RL, Sander M, Barren JC. 2000. Genomic imprinting and environmental disease susceptibility. Environ. Health Perspect. 108:271-78
77. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, et al. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:187-91
78. Judson H, Hayward BE, Sheridan E, Bonthron DT. 2002. A global disorder of imprinting in the human female germ line. Nature 416:539-42
79. Kaati G, Bygren LO, Edvinsson S. 2002. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur. J. Hum. Genet. 10:682-88
80. Kan PX, Popendikyte V, Kaminsky ZA, Yolken RH, Petronis A. 2004. Epigenetic studies of genomic retroelements in major psychosis. Schizophr. Res. 67:95-106
81. Kearns M, Preis J, McDonald M, Morris C, Whitelaw E. 2000. Complex patterns of inheritance of an imprinted murine transgene suggest incomplete germline erasure. Nucleic Acids Res. 28:3301-9
82. Kleinjan DA, van Heyningen V. 2003. Turned off by RNA. Nat. Genet. 34:125-26
83. Kleinjan DJ, van Heyningen V. 1998. Position effect in human genetic disease. Hum. Mol. Genet. 7:1611-18
84. Lachner M, Jenuwein T. 2002. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14:286-98
85. Lachner M, O'Sullivan RJ, Jenuwein T. 2003. An epigenetic road map for histone lysine methylation. J. Cell Sci. 116:2117-24
86. Lane N, Dean W, Erhardt S, Hajkova P, Surani A, et al. 2003. Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis 35:88-93
87. Lauritsen M, Ewald H. 2001. The genetics of autism. Acta Psychiatr. Scand. 103:411-27
88. Lawler SD. 1984. Genetic studies on hydatidiform moles. Adv. Exp. Med. Biol. 176:147-61
89. Lee J, Inoue K, Ono R, Ogonuki N, Kohda T, et al. 2002. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development 129:1807-17
90. Levine MA, Germain-Lee E, Jan dB. 2003. Genetic basis for resistance to parathyroid hormone. Harm. Res. 60(Suppl.) 3:87-95
91. Li E, Beard C, Jaenisch R. 1993. Role for DNA methylation in genomic imprinting. Nature 366:362-65
92. Li E, Bestor TH, Jaenisch R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-26
93. Li E. 2002. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3:662-73
94. Lin SP, Youngson N, Takada S, Seitz H, Reik W, et al. 2003. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nat. Genet. 35:97-102
95. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, et al. 2003. Allelic variation in gene expression is common in the human genome. Genome Res. 13:1855-62
96. Lusser A, Kadonaga JT. 2003. Chromatin remodeling by ATP-dependent molecular machines. Bioessays 25:1192-200
97. Maher ER, Afnan M, Barratt CL. 2003. Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs? Hum. Reprod. 18:2508-11
98. Martinowich K, Hattori D, Wu H, Fouse S, He F, et al. 2003. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890-93
99. Matarazzo MR, De Bonis ML, Gregory RI, Vacca M, Hansen RS, et al. 2002. Allelic inactivation of the pseudoautosomal gene SYBL1 is controlled by epigenetic mechanisms common to the X and Y chromosomes. Hum. Mol. Genet. 11:3191-98
100. Mattick JS. 2003. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 25:930-39
101. Matzke MA, Matzke AJ, Pruss GJ, Vance VB. 2001. RNA-based silencing strategies in plants. Curr. Opin. Genet. Dev. 11:221-27
102. McCampbell A, Taye AA, Whitty L, Penney E, Steffan JS, Fischbeck KH. 2001. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl. Acad. Sci. USA 98:15179-84
103. McGrath J, Solter D. 1984. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37:179-83
104. McKittrick E, Gafken PR, Ahmad K, Henikoff S. 2004. Histone H3.3 is enriched in covalent modifications associated with active chromatin. Proc. Natl. Acad. Sci. USA 101:1525-30
105. iapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev. 8:1463-72
106. Migeon BR, Luo S, Jani M, Jeppesen P. 1994. The severe phenotype of females with tiny ring X chromosomes is associated with inability of these chromosomes to undergo X inactivation. Am. J. Hum. Genet. 55:497-504
107. Morison IM, Reeve AE. 1998. A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum. Mol. Genet. 7:1599-609
108. Mostoslavsky R, Singh N, Tenzen T, Goldmit M, Gabay C, et al. 2001. Asynchronous replication and allelic exclusion in the immune system. Nature 414:221-25
109. Nakao M. 2001. Epigenetics: interaction of DNA methylation and chromatin. Gene 278:25-31
110. Nan X, Meehan RR, Bird A. 1993. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21:4886-92
111. Nan X, Ng HH, Johnsori CA, Laherty CD, Turner BM, et al. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-89
112. Neves G, Zucker J, Daly M, Chess A. 2004. Stochastic yet biased expression of multiple Dscam splice variants by individual cells. Nat. Genet. 36:240-46
113. Ng HH, Bird A. 1999. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9:158-63
114. Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, et al. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23:58-61
115. Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-57
116. Okano M, Xie S, Li E. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19:219-20
117. Okano M, Xie S, Li E. 1998. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 26:2536-40
118. Pal-Bhadra M, Leibovitch BA, Gandhi SG, Rao M, Bhadra U, et al. 2004. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 303:669-72
119. Pastinen T, Sladek R, Gurd S, Sammak A, Ge B, et al. 2004. A survey of genetic and epigenetic variation affecting human gene expression. Physiol. Genomics 16:184-93
120. Pembrey M. 1996. Imprinting and transgenerational modulation of gene expression; human growth as a model. Acta Genet. Med. Gemellol. (Roma.) 45:111-25
121. Pembrey ME. 2002. Time to take epigenetic inheritance seriously. Eur. J. Hum. Genet. 10:669-71
122. Petronis A. 2000. The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology 23:1-12
123. Petronis A. 2001. Human morbid genetics revisited: relevance of epigenetics. Trends Genet. 17:142-46
124. Petronis A. 2003. Epigenetics and bipolar disorder: new opportunities and challenges. Am. J. Med. Genet. 123C:65-75
125. Petronis A, Gottesman II, Kan P, Kennedy JL, Basile VS, et al. 2003. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr. Bull. 29:169-78
126. Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B. 2002. Xist RNA and the mechanism of X chromosome inactivation. Annu. Rev. Genet. 36:233-78
127. Plenge RM, Hendrich BD, Schwartz C, Arena JF, Naumova A, et al. 1997. A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation. Nat. Genet. 17:353-56
128. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, et al. 1993. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med. 329:1982-87
129. Prioleau MN, Nony P, Simpson M, Felsenfeld G. 1999. An insulator element and condensed chromatin region separate the chicken beta-globin locus from an independently regulated erythroid-specific folate receptor gene. EMBO J. 18:4035-48
130. Rakyan V, Whitelaw E. 2003. Transgenerational epigenetic inheritance. Curr. Biol. 13:R6
131. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. 2000. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 72:998-1003
132. Reik W. 1989. Genomic imprinting and genetic disorders in man. Trends Genet. 5:331-36
133. Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian development. Science 293:1089-93
134. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, et al. 1999. A genomic screen of autism: evidence for a multilocus etiology. Am. J. Hum. Genet. 65:493-507
135. Rougeulle C, Glatt H, Lalande M. 1997. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat. Genet. 17:14-15
136. Rozen R. 1996. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J. Inherit. Metab. Dis. 19:589-94
137. Saitoh N, Bell AC, Recillas-Targa F, West AG, Simpson M, et al. 2000. Structural and functional conservation at the boundaries of the chicken beta-globin domain. EMBO J. 19:2315-22
138. Sapienza C, Hall JG. 2004. Genomic imprinting in human disease. In The Metabolic and Molecular Bases of Inherited Disease, ed. Scriver, AL Beaudet, D Valle, WS Sly, pp. 417-31. New York: McGraw Hill
139. Schwann B, Rozen R. 2001. Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am. J. Pharmacogenomics. 1:189-201
140. Shaffer LG, Ledbeter DH, Lupski JR. 2001. Molecular cytogenetics of contiguous gene syndromes: mechanisms and consequences of gene dosage imbalance. In The Molecular and Metabolic Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, D Valle, WS Sly, pp. 1291-324. New York: McGraw-Hill
141. Shemer R, Birger Y, Riggs AD, Razin A. 1997. Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern. Proc. Natl. Acad. Sci. USA 94:10267-72
142. Singh N, Ebrahimi FA, Gimelbrant AA, Ensminger AW, Tackett MR, et al. 2003. Coordination of the random asynchronous replication of autosomal loci. Nat. Genet. 33:339-41
143. Spence JE, Perciaccante RG, Greig GM, Willard HF, Ledbetter DH, et al. 1988. Uniparental disomy as a mechanism for human genetic disease. Am. J. Hum. Genet. 42:217-26
144. Strohman R. 2002. Maneuvering in the complex path from genotype to phenotype. Science 296:701-3
145. Strohman RC. 1995. Linear genetics, non-linear epigenetics: complementary approaches to understanding complex diseases. Integr. Physiol. Behav. Sci. 30:273-82
146. Surti U, Hoffner L, Chakravarti A, Ferrell RE. 1990. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am. J. Hum. Genet. 47:635-43
147. Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, et al. 1994. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat. Genet. 8:52-58
148. Tada T, Tada M, Hilton K, Barton SC, Sado T, et al. 1998. Epigenotype switching of unprintable loci in embryonic germ cells. Dev. Genes Evol. 207:551-61
149. Tamaru H, Selker EU. 2001. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414:277-83
150. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, et al. 2003. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet. 34:157-65
151. Tycko B, Morison IM. 2002. Physiological functions of imprinted genes. J. Cell Physiol 192:245-58
152. Ueland PM, Refsum H. 1989. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 114:473
153. van der Put NM, Eskes TK, Blom HJ. 1997. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 90:111-15
154. Vu TH, Hoffman AR. 1994. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 371:714-17
155. Vu TH, Hoffman AR. 1997. Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat. Genet. 17:12-13
156. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP. 1999. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:62-66
157. Walter J, Paulsen M. 2003. Imprinting and disease. Semin. Cell Dev. Biol. 14:101-10
158. Warren ST, Sherman SL. 2001. The fragile X syndrome. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, D Valle, WS Sly, pp. 1257-89. New York: McGraw Hill
159. Waterland RA, Jirtle RL. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell Biol. 23:5293-300
160. Weksberg R, Smith AC, Squire J, Sadowski P. 2003. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum. Mol. Genet. 121:R61-68
161. Wijmenga C, van Deutekom JC, Hewitt JE, Padberg GW, van Ommen GJ, et al. 1994. Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions. Genomics 19:21-26
162. Wilkins JF, Haig D. 2003. What good is genomic imprinting: the function of parent-specific gene expression. Nat. Rev. Genet. 4:359-68
163. Williams CA, Zori RT, Hendrickson J, Stalker H, Marum T, et al. 1995. Angelman syndrome. Curr. Probl. Pediatr. 25:216-31
164. Wolff GL, Kodell RL, Moore SR, Cooney CA. 1998. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 12:949-57
165. Wutz A. 2003. RNAs templating chromatin structure for dosage compensation in animals. Bioessays 25:434-42
166. Xin Z, Allis CD, Wagstaff J. 2001. Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center. Am. J. Hum. Genet. 69:1389-94
167. Xin Z, Tachibana M, Guggiari M, Heard E, Shinkai Y, Wagstaff J. 2003. Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center. J. Biol. Chem. 278:14996-5000
168. Xu GL, Bester TH, Bourc'his D, Hsieh CL, Tommerup N, et al. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402:187-91
169. Yamasaki K, Joh K, Ohta T, Masuzaki H, Ishimaru T, et al. 2003. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum. Mol. Genet. 12:837-47
170. Yamazaki Y, Mann MR, Lee SS, Marh J, McCarrey JR, et al. 2003. Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning. Proc. Natl. Acad. Sci. USA 100:12207-12
171. Yntema HG, Poppelaars FA, Derksen E, Oudakker AR, van Roosmalen T, et al. 2002. Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am. J. Med. Genet. 110:243-47
172. Yoder JA, Walsh CP, Bester TH. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335-40
173. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924-35
174. Jiang Y, Sahoo T, Michaelis R, Bercovich D, Bressler J, et al. 2004. A mixed epigenetic/genetic model for oligogenic inheritance of austism with a limited role for UBE3A. Am. J. Med. Genet. In press